Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.30
    OpenPayerBilling CodesDiseases and Disorders of the Male Reproductive SystemDRG 708-major-male-pelvic-procedures-without-cc-mcc
    Ask Trek AI about this page

    Major Male Pelvic Procedures without CC/MCC: Inpatient Reimbursement Overview

    DRG 708 encompasses major male pelvic procedures performed without a Complication or Comorbidity or a Major Complication or Comorbidity, defining a mid-level resource cohort for inpatient payment. Correct clinical documentation and coding determine assignment to this Diagnosis-Related Group and therefore the Medicare inpatient reimbursement for these substantial urologic and pelvic surgeries.

    Customize your policy alerts

    Sign up for drg 708 policy alerts

    Get alerted when payer policies referencing 708 are released or updated.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    DRG 708 Overview

    DRG 708 covers major male pelvic surgical procedures without a Complication or Comorbidity and without a Major Complication or Comorbidity, typically including complex urologic operations such as radical prostatectomy or extensive pelvic exenteration when no CC or MCC is present. This Diagnosis-Related Group groups cases by similar resource use to determine inpatient payment under Medicare Severity Diagnosis-Related Group methodology. It matters for Medicare payment because assignment to this DRG establishes the base payment rate for the inpatient stay when no higher-severity complications are coded. Accurate coding of operative procedures and secondary diagnoses affects whether a case is assigned to DRG 708 or to a higher-severity group with increased reimbursement.

    Table of contents

    Progress1 / 3

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • Facility ComparisonBeds, revenue & payer mix
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    Clinical Trials

    • Trials evaluating perioperative techniques to reduce surgical morbidity for major male pelvic procedures (for example, studies comparing minimally invasive approaches versus open surgery for radical prostatectomy or pelvic exenteration-type operations). These studies enroll adult male patients undergoing high-complexity pelvic urologic or oncologic procedures and measure intraoperative metrics, complication rates, blood loss/transfusion needs, length of stay, and short-term readmissions. Results are relevant to providers for selecting operative approach and to payers because reductions in complications and shorter hospital stays can lower inpatient costs and downstream resource use.
    • Comparative effectiveness studies of perioperative risk-reduction bundles and enhanced recovery protocols tailored to major male pelvic surgery patients (for example, multimodal analgesia, fluid management, venous thromboembolism prophylaxis, and early mobilization protocols). These trials typically target older men or those with comorbidities undergoing pelvic procedures and evaluate outcomes such as postoperative infection, ileus, opioid consumption, discharge disposition, and 30-day readmission or complication rates. Evidence from these studies informs clinical pathways that can standardize care, improve outcomes, and potentially reduce variability in reimbursement and length-of-stay for this high-cost DRG.
    • Longitudinal outcomes and quality-of-life studies following major male pelvic procedures, focusing on functional outcomes (urinary continence, sexual function), long-term complications (fistula, strictures), and health-related quality of life and resource utilization after discharge. These observational cohorts or pragmatic trials follow patients for months to years post-discharge to capture re-interventions, outpatient care needs, and durable impacts on independence and return to work. Payers and hospital administrators use this evidence to anticipate post-acute service needs, design bundled payment models, and assess the total cost of care beyond the index hospitalization.

    Related Codes

    707-MAJOR-MALE-PELVIC-PROCEDURES-WITH-CC-MCC

    Major Male Pelvic Procedures with CC/MCC: Inpatient Reimbursement Overview

    709-PENIS-PROCEDURES-WITH-CC-MCC

    Penis Procedures with CC/MCC: Inpatient Reimbursement Overview

    710-PENIS-PROCEDURES-WITHOUT-CC-MCC

    Penis Procedures without CC/MCC: Inpatient Reimbursement Overview

    711-TESTES-PROCEDURES-WITH-CC-MCC

    Testes Procedures with CC/MCC: Inpatient Reimbursement Overview

    712-TESTES-PROCEDURES-WITHOUT-CC-MCC

    Testes Procedures without CC/MCC: Inpatient Reimbursement Overview

    713-TRANSURETHRAL-PROSTATECTOMY-WITH-CC-MCC

    Transurethral Prostatectomy with CC/MCC: Inpatient Reimbursement Overview

    714-TRANSURETHRAL-PROSTATECTOMY-WITHOUT-CC-MCC

    Transurethral Prostatectomy without CC/MCC: Inpatient Reimbursement Overview

    715-OTHER-MALE-REPRODUCTIVE-SYSTEM-O-R-PROCEDURES-FOR-MALIGNANCY-WITH-CC-MCC

    Other Male Reproductive System O.R. Procedures for Malignancy with CC/MCC: Inpatient Reimbursement Overview

    716-OTHER-MALE-REPRODUCTIVE-SYSTEM-O-R-PROCEDURES-FOR-MALIGNANCY-WITHOUT-CC-MCC

    Other Male Reproductive System O.R. Procedures for Malignancy without CC/MCC: Inpatient Reimbursement Overview

    717-OTHER-MALE-REPRODUCTIVE-SYSTEM-O-R-PROCEDURES-EXCEPT-MALIGNANCY-WITH-CC-MCC

    Other Male Reproductive System O.R. Procedures Except Malignancy with CC/MCC: Inpatient Reimbursement Overview

    Showing 1–10 of 20

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.